<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Guaiac tests are the most widely used tests to detect <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>However, their sensitivity is relatively low and results may be affected by various factors </plain></SENT>
<SENT sid="2" pm="."><plain>Immunofecal occult blood test (IFOBT) is specific for human <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> and does not require dietary restrictions </plain></SENT>
<SENT sid="3" pm="."><plain>AIMS: The aim of this study was to evaluate the effectiveness of IFOBT for the screening of <z:e sem="disease" ids="C0940937" disease_type="Neoplastic Process" abbrv="">precancerous lesions</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: From July 2006 to June 2007, IFOBT was performed on 5,919 adults who received periodic health examinations in our hospital </plain></SENT>
<SENT sid="5" pm="."><plain>The positive cases were examined by colonoscopy and a double-contrast <z:chebi fb="8" ids="32594,32595">barium</z:chebi> enema </plain></SENT>
<SENT sid="6" pm="."><plain>Diagnosis was confirmed by histopathological analysis </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Positive IFOBT was detected in 314 of 5,919 cases (5.30%) </plain></SENT>
<SENT sid="8" pm="."><plain>Further examinations were made in 264 IFOBT-positive cases </plain></SENT>
<SENT sid="9" pm="."><plain>Of these, 116 cases with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (16 cases) or <z:e sem="disease" ids="C0940937" disease_type="Neoplastic Process" abbrv="">precancerous lesions</z:e> (94 cases with colorectal <z:mpath ids='MPATH_490'>adenomatous polyps</z:mpath> and 6 cases with active <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo>) were detected </plain></SENT>
<SENT sid="10" pm="."><plain>The total detection rate of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and <z:e sem="disease" ids="C0940937" disease_type="Neoplastic Process" abbrv="">precancerous lesions</z:e> was 43.94% (116/264) </plain></SENT>
<SENT sid="11" pm="."><plain>TNM classification of 16 CRC cases was as follows: TNM I in eight cases (50.00%), TNM II in seven cases (43.75%) and TNM III in one case (6.25%), indicating IFOBT can detect <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in the early stages </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: Regular IFOBT can detect <z:e sem="disease" ids="C0940937" disease_type="Neoplastic Process" abbrv="">precancerous lesions</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in early stages and can thus reduce mortality from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>